Abstract
Ankaferd blood stopper (ABS) is a hemostatic agent that induces clot formation by a special protein network which mainly causes powerful erythrocyte aggregation. The use of topical ABS as a hemostatic agent has been approved in Turkey for the management of dermal, external post-surgical and post-dental surgery bleeding. ABS has been successfully used in Dieulafoy lesion and bleeding from gastrointestinal neoplasms. We present a patient with alcoholic cirrhosis who developed severe bleeding during an elective endoscopic variceal ligation (EVL) session due to immediate band slippage, in whom endoscopic topical application of ABS was associated with cessation of bleeding. The major advantages of ABS appear to be ease of use and lack of side effect.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Goker H, Haznedaroglu IC, Ercetin S, et al. Haemostatic actions of the folkloric medicinal plant extract, Ankaferd blood stopper. J Int Med Res. 2008;36:163–70.
Haznedaroglu BZ, Haznedaroglu IC, Walker SL, et al. Ultrastructural and morphological analyses of the ın vitro and ın vivo hemostatic effects of Ankaferd blood stopper. Clin Appl Thromb Hemost. 2010;16:446–53.
Kurt M, Kacar S, Onal IK, Akdogan M, Haznedaroglu IC. Ankaferd blood stopper as an effective adjunctive hemostatic agent for the management of life-threatening arterial bleeding of the digestive tract. Endoscopy. 2008;40 Suppl 2:E262.
Kurt M, Akdogan M, Onal IK, et al. Endoscopic topical application of Ankaferd blood stopper for neoplastic gastrointestinal bleeding: a retrospective analysis. Dig Liver Dis. 2010;42:196–9.
Ozaslan E, Purnak T, Yildiz A, Haznedaroglu IC. A new practical alternative for tumoural gastrointestinal bleeding: Ankaferd blood stopper. Dig Liver Dis. 2010;42:594–5.
Ozaslan E, Purnak T, Yildiz A, Akar T, Avcioglu U, Haznedaroglu IC. The effect of Ankaferd blood stopper on severe radiation colitis. Endoscopy. 2009;41 Suppl 2:E321–2.
Sakai P, Maluf Filho F, Melo JM, Ishioka S. Is endoscopic band ligation of esophageal varices contraindicated in Child-Pugh C patients? Endoscopy. 1994;26:511–2.
Mishin I, Dolghii A. Early spontaneous slippage of rubber bands with fatal bleeding: a rare complication of endoscopic variceal ligation. Endoscopy. 2005;37:275–6.
Garcia-Tsao G, Sanyal AJ, Grace ND, Carey W. Practice guidelines committee of the American Association for the Study of Liver Diseases; Practice Parameters Committee of the American College of Gastroenterology. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology. 2007;46:922–38.
Bilgili H, Captug O, Kosar A, et al. Oral systemic administration of Ankaferd blood stopper has no short-term toxicity in an in vivo rabbit experimental model. Clin Appl Thromb Hemost. 2009 Jul 14. [Epub ahead of print]
Kurt M, Oztas E, Kuran S, Onal IK, Kekilli M, Haznedaroglu IC. Tandem oral, rectal, and nasal administrations of Ankaferd blood stopper to control profuse bleeding leading to hemodynamic instability. Am J Emerg Med. 2009;27(631):e1–2.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ozaslan, E., Purnak, T., Yildiz, A. et al. Bleeding due to slippage of elastic band during variceal ligation: successful use of Ankaferd blood stopper. Indian J Gastroenterol 29, 166–168 (2010). https://doi.org/10.1007/s12664-010-0043-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12664-010-0043-y